Spondyloarthritis & psoriatic arthritis

Construct validity and responsiveness of ASAS Health Index assessed in two longitudinal studies of tumour necrosis factor alpha inhibitor initiation and dose reduction in patients with axial spondyloarthritis

RMD OpenPublished Validation study

Authors' conclusion

ASAS HI showed good construct validity, discriminatory ability and responsiveness.

Study context

Population
Patients with axial spondyloarthritis (SpA) initiating or tapering tumour necrosis factor inhibitor (TNFi)
Participants
45 vs 106
Comparison
MANGO vs DOBIS
  • MANGOn = 45
  • DOBISn = 106
Outcome
Construct validity, discriminatory ability and responsiveness of ASAS HI in relation to patient-reported outcome measures (PROMs), MRI and radiography
Methodological detailssecondary analysis of two longitudinal studies, multivariate regression
  • Secondary analysis of two longitudinal studies
  • Multivariate regression

Performance

As reported in the abstract

Responsiveness of ASAS HI
Test or modelStandardised response mean (SRM)Effect size (ES)
MANGO−1.3−1.7
DOBIS0.70.6

Standardised response mean (SRM)

MANGO−1.3
DOBIS0.7

Effect size (ES)

MANGO−1.7
DOBIS0.6
Good discriminatory ability for almost all outcome variables by ASAS HI health status groups and change categories
P ≤ 0.001

Further findings

Clinical responders at week 16 (MANGO)
68% · 30
Flare after tapering (DOBIS)
99% · 105 of 106
Time to flare (DOBIS)
31 · mean · SD; min-max 17; 2.7-81 · weeks

Change in ASAS HI over time

MANGO: ASAS HI significantly decreased from baseline to week 4, 16 and 52
DOBIS: significantly increased from baseline to flare and significantly decreased from flare to week 96

Original publication

Construct validity and responsiveness of ASAS Health Index assessed in two longitudinal studies of tumour necrosis factor alpha inhibitor initiation and dose reduction in patients with axial spondyloarthritis. RMD Open. Published 20 December 2024. doi:10.1136/rmdopen-2024-004948

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.